Trial
NCT01857726
Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Seoul National University Hospital
Collaborators
—
Condition
Hepatocellular Carcinoma
Intervention
Doxorubicin
Why stopped
No participants were enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-04-28